May Wang
Corporate Officer/Principal at HUTCHMED (CHINA) LIMITED
May Wang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HUTCHMED (CHINA) LIMITED | Corporate Officer/Principal | 31/12/2009 | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 26/07/2011 | - |
Career history of May Wang
Former positions of May Wang
| Companies | Position | Start | End |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Training of May Wang
| Purdue University | Doctorate Degree |
Statistics
International
| United States | 3 |
| China | 2 |
| Hong Kong | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| HUTCHMED (CHINA) LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- May Wang
- Experience
